Trisubstituted and tetrasubstituted pyrazolines as a novel class of cell-growth inhibitors in tumor cells with wild type p53

  • Mohammad Abdel-Halim, Adam B. Keeton, Evrim Gurpinar, Bernard D. Gary, Simon M. Vogel, Matthias Engel, Gary A. Piazza, Frank M. Boeckler, Rolf W. Hartmann, Ashraf H. Abadi
  • Bioorganic & Medicinal Chemistry, December 2013, Elsevier
  • DOI: 10.1016/j.bmc.2013.09.055

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1016/j.bmc.2013.09.055

The following have contributed to this page: Professor Ashraf H. Abadi